Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Six Questions For Merck's Stein On Beating The Competition And Staying Relevant in Diabetes

This article was originally published in Scrip

Executive Summary

During the European Association for the Study of Diabetes meeting in Stockholm this week, the severity of the current disease crisis was impressed upon delegates at every turn. Few presentations failed to include dire warnings of the increasing diabetes epidemic, followed by reminders that over half of those diagnosed with the disease are inadequately treated on current therapies.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register